What Akebia Therapeutics Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 1 |
| Sells | 0 | 16 |
| Total trades | 1 | 31 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 350,000 | 2,432,720 |
| Disposed | 0 | 704,058 |
| Net activity | +350,000 | +1,728,662 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Butler John P. | CEO and President | Aug 06 | Exercise / conversion · M | +350,000 | $0.63 | +$221K | 3,718,564 |
| Ostrowski Erik | SVP, CFO, CBO & Treasurer | Jun 29 | Sale for tax withholding · S | −56,019 | $1.11 | −$62.2K | 616,616 |
| Adams Adrian | Director | Jun 17 | Grant / award · A | +35,700 | — | — | 236,200 |
| Zumwalt Leanne M | Director | Jun 17 | Grant / award · A | +35,700 | — | — | 145,100 |
| Frieson Ron | Director | Jun 17 | Grant / award · A | +35,700 | — | — | 165,200 |
| Rogers Michael W | Director | Jun 17 | Grant / award · A | +35,700 | — | — | 197,429 |
| Smith Cynthia | Director | Jun 17 | Grant / award · A | +35,700 | — | — | 196,633 |
| Wolf Myles | Director | Jun 17 | Grant / award · A | +35,700 | — | — | 169,081 |
| Butler John P. | CEO and President | Mar 04 | Open-market buy · P | +69,270 | $1.25 | +$86.6K | 3,367,064 |
| Butler John P. | CEO and President | Feb 02 | Sale for tax withholding · S | −83,689 | $1.39 | −$116K | 3,297,794 |
| Butler John P. | CEO and President | Feb 02 | Grant / award · A | +175,250 | $1.41 | +$247K | 3,381,483 |
| Butler John P. | CEO and President | Feb 02 | Sale for tax withholding · S | −114,891 | $1.39 | −$160K | 3,206,233 |
| Butler John P. | CEO and President | Feb 02 | Sale for tax withholding · S | −96,065 | $1.39 | −$134K | 3,321,124 |
| Butler John P. | CEO and President | Feb 02 | Sale for tax withholding · S | −46,660 | $1.39 | −$64.9K | 3,417,189 |
| Ostrowski Erik | SVP, CFO, CBO & Treasurer | Feb 02 | Sale for tax withholding · S | −34,951 | $1.39 | −$48.6K | 672,635 |
| Rucci Carolyn M. | SVP, Chief Legal Officer | Feb 02 | Sale for tax withholding · S | −27,544 | $1.39 | −$38.3K | 588,378 |
| Rucci Carolyn M. | SVP, Chief Legal Officer | Feb 02 | Sale for tax withholding · S | −25,382 | $1.39 | −$35.3K | 615,922 |
| Rucci Carolyn M. | SVP, Chief Legal Officer | Feb 02 | Sale for tax withholding · S | −16,846 | $1.39 | −$23.4K | 641,304 |
| Burke Steven Keith | SVP, Chief Medical Officer | Feb 02 | Sale for tax withholding · S | −20,701 | $1.39 | −$28.8K | 948,432 |
| Burke Steven Keith | SVP, Chief Medical Officer | Feb 02 | Sale for tax withholding · S | −25,375 | $1.39 | −$35.3K | 969,133 |
Loading...
